NCT01217996 Computerized Intervention for Amelioration of Cognitive Late Effects Among Childhood Cancer Survivors Status COMPLETED Phase NA
NCT01180881 Neurobehavioral Functioning in Pediatric Brain Tumor Patients After Proton Beam Radiation Treatment Status COMPLETED Phase N/A
NCT01171469 Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor Status COMPLETED Phase PHASE1
NCT01130623 A Phase I Study of Pazopanib as a Single Agent for Children With Refractory Solid Tumors Status WITHDRAWN Phase PHASE1
NCT01130220 Study of the Health Information Needs of Brain Cancer Patients Status COMPLETED Phase N/A
NCT01128465 Pharmacokinetic and -Dynamic of Propofol During Awake Craniotomy Status COMPLETED Phase N/A
NCT01125826 Cell Culture of Glioma Specimens for in Vitro Preclinical Studies Status UNKNOWN Phase N/A
NCT01111097 Study of the Safety and Efficacy of Dichloroacetate (DCA) in Glioblastoma and Other Recurrent Brain Tumors Status COMPLETED Phase PHASE1
NCT01095094 Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma Status TERMINATED Phase PHASE2
NCT01082926 Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2 Status COMPLETED Phase PHASE1
NCT01048684 Comparison of Two Doses of Mannitol on Brain Relaxation During Supratentorial Craniotomy Status COMPLETED Phase NA
NCT01044966 A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma Status TERMINATED Phase PHASE1/PHASE2
NCT01018329 Magnetic Resonance Imaging in Evaluating Response to RadiationTherapy in Patients With High Grade Glioma Status COMPLETED Phase NA
NCT00952081 A Pilot Study to Evaluate Efficacy and Safety of Clevidipine in Neurosurgical Patients Status COMPLETED Phase PHASE4
NCT00939991 Suberoylanilide Hydroxamic Acid (SAHA), Bevacizumab, Daily Temozolomide for Recurrent Malignant Gliomas Status COMPLETED Phase PHASE1/PHASE2